• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV 感染的自然史。

The natural history of HIV infection.

机构信息

Research Department of Infection and Population Health, University College London (UCL), Royal Free Campus, London, UK.

出版信息

Curr Opin HIV AIDS. 2013 Jul;8(4):311-7. doi: 10.1097/COH.0b013e328361fa66.

DOI:10.1097/COH.0b013e328361fa66
PMID:23698562
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4196796/
Abstract

PURPOSE OF REVIEW

To review recent published literature around three areas: long-term nonprogression/viral control; predictors of viral load set point/disease progression; and the potential impact of antiretroviral therapy (ART) in early HIV infection.

RECENT FINDINGS

The natural course of untreated HIV infection varies widely with some HIV-positive individuals able to maintain high CD4 cell counts and/or suppressed viral load in the absence of ART. Although similar, the underlying mechanistic processes leading to long-term nonprogression and viral control are likely to differ. Concerted ongoing research efforts will hopefully identify host factors that are causally related to these phenotypes, thus providing opportunities for the development of novel treatment or preventive strategies. Although there is increasing evidence that initiation of ART during primary infection may prevent the immunological deterioration which would otherwise be seen in untreated HIV infection, recent studies do not address the longer term clinical benefits of ART at this very early stage.

SUMMARY

A better understanding of the relative influences of viral, host, and environmental factors on the natural course of HIV infection has the potential to identify novel targets for intervention to prevent and treat HIV-infected persons.

摘要

目的综述

回顾近期发表的文献,重点关注三个方面:长期无进展/病毒控制;病毒载量基准/疾病进展的预测因素;以及抗逆转录病毒疗法(ART)在早期 HIV 感染中的潜在影响。

最近的发现

未经治疗的 HIV 感染的自然病程差异很大,一些 HIV 阳性个体在没有 ART 的情况下能够维持高 CD4 细胞计数和/或抑制病毒载量。尽管相似,但导致长期无进展和病毒控制的潜在机制过程可能不同。持续的协同研究工作有望确定与这些表型有因果关系的宿主因素,从而为开发新的治疗或预防策略提供机会。尽管越来越多的证据表明,在原发性感染期间开始 ART 可能预防未经治疗的 HIV 感染中会出现的免疫恶化,但最近的研究并未解决在这一非常早期阶段开始 ART 的更长期临床获益问题。

总结

更好地了解病毒、宿主和环境因素对 HIV 感染自然病程的相对影响,有可能为预防和治疗 HIV 感染者确定新的干预目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93cf/4196796/83bebbe89b8e/cohiv-8-311-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93cf/4196796/2d33c9212673/cohiv-8-311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93cf/4196796/83bebbe89b8e/cohiv-8-311-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93cf/4196796/2d33c9212673/cohiv-8-311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93cf/4196796/83bebbe89b8e/cohiv-8-311-g002.jpg

相似文献

1
The natural history of HIV infection.HIV 感染的自然史。
Curr Opin HIV AIDS. 2013 Jul;8(4):311-7. doi: 10.1097/COH.0b013e328361fa66.
2
Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.成人慢性未抑制的HIV感染中的结构化治疗中断(STI)
Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD006148. doi: 10.1002/14651858.CD006148.
3
Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts.在HIV感染中,抗逆转录病毒治疗的早期启动而非长期持续时间有助于CD8 T细胞计数正常化。
Clin Infect Dis. 2016 Jan 15;62(2):250-257. doi: 10.1093/cid/civ809. Epub 2015 Sep 8.
4
[Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)].[西班牙艾滋病研究与治疗合作组/国家艾滋病计划关于HIV感染成人抗逆转录病毒治疗的建议(2004年10月)]
Enferm Infecc Microbiol Clin. 2004 Dec;22(10):564-642. doi: 10.1157/13069520.
5
Harnessing CD8 T Cells Under HIV Antiretroviral Therapy.在 HIV 抗逆转录病毒治疗下利用 CD8 T 细胞。
Front Immunol. 2019 Feb 26;10:291. doi: 10.3389/fimmu.2019.00291. eCollection 2019.
6
Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.早期抗逆转录病毒治疗可增强 CD4+ T 细胞恢复。
N Engl J Med. 2013 Jan 17;368(3):218-30. doi: 10.1056/NEJMoa1110187.
7
No change in viral set point or CD4 cell decline among antiretroviral treatment-naïve, HIV-1-infected individuals enrolled in the Danish HIV Cohort Study in 1995-2010.在 1995-2010 年参加丹麦 HIV 队列研究的未接受抗逆转录病毒治疗的 HIV-1 感染个体中,病毒设定点或 CD4 细胞下降没有变化。
HIV Med. 2013 Jul;14(6):362-9. doi: 10.1111/hiv.12016. Epub 2013 Feb 21.
8
Structured treatment interruptions (STI) in chronic suppressed HIV infection in adults.成人慢性抑制性HIV感染中的结构化治疗中断(STI)
Cochrane Database Syst Rev. 2005 Oct 19(4):CD005482. doi: 10.1002/14651858.CD005482.
9
HIV in the UK 1980-2006: reconstruction using a model of HIV infection and the effect of antiretroviral therapy.英国1980 - 2006年的艾滋病病毒:利用艾滋病病毒感染模型进行重建以及抗逆转录病毒疗法的效果
HIV Med. 2007 Nov;8(8):536-46. doi: 10.1111/j.1468-1293.2007.00507.x.
10
HLA B*5701 status, disease progression, and response to antiretroviral therapy.人类白细胞抗原 B*5701 状态、疾病进展和抗逆转录病毒治疗反应。
AIDS. 2013 Oct 23;27(16):2587-92. doi: 10.1097/01.aids.0000432613.95455.71.

引用本文的文献

1
Global, regional, and national burden and trends of HIV/AIDS among women of childbearing age from 1990 to 2021: results from Global Burden of Disease 2021.1990年至2021年全球、区域和国家育龄妇女中艾滋病毒/艾滋病的负担及趋势:全球疾病负担研究2021年结果
Front Med (Lausanne). 2025 Jul 4;12:1605092. doi: 10.3389/fmed.2025.1605092. eCollection 2025.
2
T cell-mediated Immune response and correlates of inflammation and their relationship with COVID-19 clinical severity: not an intuitive guess.T 细胞介导的免疫反应及炎症相关指标与 COVID-19 临床严重程度的关系:并非直观猜测。
BMC Infect Dis. 2024 Jun 20;24(1):612. doi: 10.1186/s12879-024-09490-y.
3

本文引用的文献

1
Mutations in the nef and vif genes associated with progression to AIDS in elite controller and slow-progressor patients.与精英控制者和缓慢进展者进展为艾滋病相关的 nef 和 vif 基因中的突变。
J Med Virol. 2013 Apr;85(4):563-74. doi: 10.1002/jmv.23512. Epub 2013 Jan 28.
2
Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.早期抗逆转录病毒治疗可增强 CD4+ T 细胞恢复。
N Engl J Med. 2013 Jan 17;368(3):218-30. doi: 10.1056/NEJMoa1110187.
3
Short-course antiretroviral therapy in primary HIV infection.原发性 HIV 感染的短程抗逆转录病毒治疗。
Survival Analysis and Immune Differences of HIV Long-Term Non-progressors in Xinjiang China: A 12-Year Prospective Cohort Observation.
中国新疆地区 HIV 长期非进展者的生存分析及免疫差异:一项为期 12 年的前瞻性队列观察。
AIDS Behav. 2024 Sep;28(9):3151-3160. doi: 10.1007/s10461-024-04396-x. Epub 2024 Jun 13.
4
Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection.探讨 HIV 感染中的慢性炎症、免疫代谢和 T 细胞功能障碍。
Viruses. 2024 Jan 31;16(2):219. doi: 10.3390/v16020219.
5
Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management.艾滋病毒感染者中心血管疾病的发病机制和临床表现的演变:对治疗的影响。
Clin Microbiol Rev. 2024 Mar 14;37(1):e0009822. doi: 10.1128/cmr.00098-22. Epub 2024 Feb 1.
6
Kaempferol: A Review of Current Evidence of Its Antiviral Potential.山奈酚:其抗病毒潜力的当前证据综述。
Int J Mol Sci. 2023 Nov 14;24(22):16299. doi: 10.3390/ijms242216299.
7
Single-Cell Transcriptomics of /HIV Co-Infection.单细胞转录组学分析 /HIV 共感染。
Cells. 2023 Sep 17;12(18):2295. doi: 10.3390/cells12182295.
8
The role of tunneling nanotubes during early stages of HIV infection and reactivation: implications in HIV cure.隧道纳米管在HIV感染和再激活早期阶段的作用:对HIV治愈的影响。
NeuroImmune Pharm Ther. 2023 Jan 4;2(2):169-186. doi: 10.1515/nipt-2022-0015. eCollection 2023 Jun.
9
Association between mental disorders and adherence to antiretroviral treatment in health facilities in two Mozambican provinces in 2018: a cross-sectional study.2018 年莫桑比克两个省份医疗机构中精神障碍与抗逆转录病毒治疗依从性的相关性:一项横断面研究。
BMC Psychiatry. 2023 Apr 20;23(1):274. doi: 10.1186/s12888-023-04782-0.
10
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project.大学医院中基于HIV感染指示疾病的主动病例发现:SHOT项目的结果。
Infect Dis Rep. 2023 Jan 29;15(1):94-101. doi: 10.3390/idr15010010.
N Engl J Med. 2013 Jan 17;368(3):207-17. doi: 10.1056/NEJMoa1110039.
4
Early immunologic and virologic predictors of clinical HIV-1 disease progression.早期免疫和病毒学预测因素与 HIV-1 临床疾病进展的关系。
AIDS. 2013 Mar 13;27(5):697-706. doi: 10.1097/QAD.0b013e32835ce2e9.
5
Cumulative impact of host and viral factors on HIV-1 viral-load control during early infection.宿主和病毒因素对早期感染期间 HIV-1 病毒载量控制的累积影响。
J Virol. 2013 Jan;87(2):708-15. doi: 10.1128/JVI.02118-12. Epub 2012 Oct 31.
6
Partner characteristics predicting HIV-1 set point in sexually acquired HIV-1 among African seroconverters.非洲血清转化者中,预测性传播HIV-1感染后HIV-1设定值的伴侣特征。
AIDS Res Hum Retroviruses. 2013 Jan;29(1):164-71. doi: 10.1089/AID.2012.0206.
7
Short communication: HIV+ viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation.简短通讯:HIV 病毒血症进展缓慢者直肠黏膜中调节性 T 细胞数量维持在低水平,但 T 细胞活化程度较高。
AIDS Res Hum Retroviruses. 2013 Jan;29(1):172-7. doi: 10.1089/AID.2012.0268. Epub 2012 Oct 16.
8
Restricting HIV the SAMHD1 way: through nucleotide starvation.通过核苷酸饥饿限制 HIV:SAMHD1 之道。
Nat Rev Microbiol. 2012 Oct;10(10):675-80. doi: 10.1038/nrmicro2862. Epub 2012 Aug 28.
9
Time to virological failure, treatment change and interruption for individuals treated within 12 months of HIV seroconversion and in chronic infection.在HIV血清转化后12个月内接受治疗的个体以及慢性感染个体的病毒学失败时间、治疗改变和中断情况。
Antivir Ther. 2012;17(6):1039-48. doi: 10.3851/IMP2312. Epub 2012 Aug 15.
10
Disease Progression in HIV-1-Infected Viremic Controllers.HIV-1 感染者病毒血症中的疾病进展。
J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):407-16. doi: 10.1097/QAI.0b013e318269c414.